Gara Jalqabaatti › Ocular Hypertension › Texas
Qorannoo klinikaalii Ocular Hypertension Texas keessatti
Qorannoo 8 Ocular Hypertension f Texas keessatti hirmaatuu jiru.
Magaalota Texas keessatti
Takkalaa qorannoo (Ingiliffa)
iDose TR Administration in an Office-Based Surgery Setting
- Glaukos Investigative Site, Austin
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07816692A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
- Houston Eye Associates, Houston
- R and R eye research, San Antonio
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07661329Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- Glaukos Clinical Site, El Paso
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07075718Clarifying the Optimal Application of SLT Therapy Trial
- Ophthalmology Associates, Fort Worth
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT04967989Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
- R and R Eye Research, LLC, San Antonio
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 22 fi ol · Saalaa hunda · Haaromfame 20-Onk-2025 · NCT07218796Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
- Houston Eye Associates, Houston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 22 fi ol · Saalaa hunda · Haaromfame 20-Onk-2025 · NCT07218783Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
- Wilford Hall Ambulatory Surgical Center, Lackland Air Force Base
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2023 · NCT05844384Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
- Keystone Research, Austin
- Houston Eye Associates, North Loop, Houston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2022 · NCT05401357Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.